213 related articles for article (PubMed ID: 15907827)
21. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A; Harris CL; Court J; Mason MD; Morgan BP
Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
23. Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer.
Chen R; Eshleman JR; Brodsky RA; Medof ME
Cancer Res; 2001 Jan; 61(2):654-8. PubMed ID: 11212264
[TBL] [Abstract][Full Text] [Related]
24. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
Ruan GR; Qin YZ; Chen SS; Li JL; Ma X; Chang Y; Wang YZ; Fu JY; Liu YR
Leuk Res; 2006 Sep; 30(9):1159-65. PubMed ID: 16507320
[TBL] [Abstract][Full Text] [Related]
25. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
Qin YZ; Ruan GR; Liu YR; Li JL; Fu JY; Wang H; Chang Y; Jiang B; Jiang Q; Jiang H; Qiu JY; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):1-5. PubMed ID: 15946498
[TBL] [Abstract][Full Text] [Related]
26. [Cyclin D2 expression in chronic myelogenous leukemia].
Song JM; Xu D; Fan EJ; Xu SR; Li D; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):103-5. PubMed ID: 14990053
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
[TBL] [Abstract][Full Text] [Related]
28. [The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine].
Sun JR; Zhang XH; He ZW; Gu Y; Yu YZ; Fang YM; Lü QH; Dong QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2246-51. PubMed ID: 17064567
[TBL] [Abstract][Full Text] [Related]
29. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
[TBL] [Abstract][Full Text] [Related]
30. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
31. Detection of stem cell factor mRNA expression in leukemic cells by in situ reverse transcriptase-PCR.
Wu B; Liu XL; Xuan WL; Feng R; Yin F; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):490-2. PubMed ID: 12297464
[TBL] [Abstract][Full Text] [Related]
32. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
33. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.
Metz CN; Brunner G; Choi-Muira NH; Nguyen H; Gabrilove J; Caras IW; Altszuler N; Rifkin DB; Wilson EL; Davitz MA
EMBO J; 1994 Apr; 13(7):1741-51. PubMed ID: 7512501
[TBL] [Abstract][Full Text] [Related]
34. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
35. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
36. How Glycosylphosphatidylinositol-phospholipase D acts in homing of hematopoietic stem/progenitor cells?
Song K; Sun X; Wang J; Chen F
Med Hypotheses; 2007; 69(3):660-5. PubMed ID: 17368745
[TBL] [Abstract][Full Text] [Related]
37. [Preliminary study of the gene structure of human glycosylphosphatidylinositol specific phospholipase D].
Tang JH; Gu SL; Zhang XJ
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):95-7. PubMed ID: 12536633
[TBL] [Abstract][Full Text] [Related]
38. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
39. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
[TBL] [Abstract][Full Text] [Related]
40. Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes.
O'Brien KD; Pineda C; Chiu WS; Bowen R; Deeg MA
Circulation; 1999 Jun; 99(22):2876-82. PubMed ID: 10359731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
